NCT00005842View on ClinicalTrials.gov

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

February 29, 2004

Conditions
Cancer
Interventions
BIOLOGICAL

trastuzumab

DRUG

tipifarnib

Trial Locations (2)

78234

Brooke Army Medical Center, Fort Sam Houston

78245-3217

Institute for Drug Development, San Antonio

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00005842 - Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | Biotech Hunter | Biotech Hunter